Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China · Delayed Price · Currency is CNY 74.11
+1.75 (2.42%)
At close: Jan 23, 2026
SHE:301033 Revenue
Medprin Regenerative Medical Technologies had revenue of 91.45M CNY in the quarter ending September 30, 2025, with 32.74% growth. This brings the company's revenue in the last twelve months to 336.73M, up 21.99% year-over-year. In the year 2024, Medprin Regenerative Medical Technologies had annual revenue of 278.44M with 20.61% growth.
Revenue (ttm)
336.73M
Revenue Growth
+21.99%
P/S Ratio
14.68
Revenue / Employee
999.20K
Employees
337
Market Cap
4.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 278.44M | 47.57M | 20.61% |
| Dec 31, 2023 | 230.87M | 35.62M | 18.24% |
| Jan 1, 2023 | 195.25M | 41.47M | 26.96% |
| Jan 1, 2022 | 153.79M | 30.27M | 24.51% |
| Dec 31, 2020 | 123.51M | 10.27M | 9.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GKHT Medical Technology | 7.22B |
| Wuhan Huakang Century Clean Technology | 2.06B |
| Getein Biotech | 1.04B |
| Shanghai Kinetic Medical | 1.02B |
| Zhejiang Orient Gene Biotech | 842.11M |
| Hangzhou AGS MedTech | 668.70M |
| Chison Medical Technologies | 449.62M |
| Nanjing Medlander Medical Technology | 437.82M |